ResMed (RMD) Form 144 Filed for 100-Share Sale via Fidelity

Rhea-AI Filing Summary

ResMed (RMD) filed a Form 144 proposing the sale of 100 shares of common stock through Fidelity Brokerage Services with an approximate market value of $27,436, scheduled for 10/01/2025. The shares were acquired by restricted stock vesting on 11/11/2023 and were granted as compensation. The filer previously sold 66 shares on 07/01/2025 for $16,961.34 and 50 shares on 08/01/2025 for $14,095.00. The filing includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.

Positive

• Compliance with Rule 144 disclosure requirements by providing broker, acquisition, and sale details
• Transparency about prior sales on 07/01/2025 and 08/01/2025 with gross proceeds disclosed

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider Form 144 disclosing a small, post-vesting sale; immaterial to company capitalization.

The filing reports a proposed sale of 100 shares acquired via restricted stock vesting on 11/11/2023 and designated as compensation. The disclosed aggregate market value ($27,436) and the small quantity relative to total outstanding shares (146,414,839) indicate the transaction is unlikely to be materially dilutive or price-moving. Prior recent sales of 66 and 50 shares are listed, consistent with staged dispositions under Rule 144. This appears to be a compliance-driven disclosure of insider sales rather than a company-level operational event.

Corporate Governance Expert

TL;DR: Filing meets Rule 144 reporting requirements and includes the seller's attestation about material nonpublic information.

The Form 144 supplies required broker, acquisition, and sale details and repeats the statutory attestation concerning material nonpublic information. Acquisition through restricted stock vesting and subsequent scheduled sales align with standard executive compensation monetization practices. From a governance perspective, the filing demonstrates procedural compliance and transparency but does not itself signal governance changes or disclosures of internal issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	100	27436.00	146414839	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2023	Restricted Stock Vesting	Issuer			100	11/11/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael J. Rider 9001 Spectrum Center Blvd. San Diego CA 92123	Common	07/01/2025	66	16961.34
Michael J. Rider 9001 Spectrum Center Blvd. San Diego CA 92123	Common	08/01/2025	50	14095.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the RMD Form 144 disclose?

The filing discloses a proposed sale of 100 common shares via Fidelity with an aggregate market value of $27,436, approximate sale date 10/01/2025.

How were the 100 shares acquired according to the filing?

The shares were acquired by restricted stock vesting on 11/11/2023 and were granted as compensation.

Has the filer sold other RMD shares recently?

Yes. The filer sold 66 shares on 07/01/2025 for $16,961.34 and 50 shares on 08/01/2025 for $14,095.00.

Who is the broker handling the proposed sale?

The broker listed is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917.

Does the filing state whether the seller has material nonpublic information?

Yes. The seller represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.